Biofrontera Inc. acquires full U.S. rights to Ameluz® and RhodoLED®, including New Drug Application and associated patents, from former parent…
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery…
PALO ALTO, CA / ACCESS Newswire / October 23, 2025 / Bioz, Inc., the industry-standard AI citation solution built to…
SÃO PAULO, Oct. 22, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing essential tools and technologies…
"The ex-New Jersey Attorney General and former DEA Administrator promised to modernize justice through data. Instead, under her watch, illegal…
The following is a corrected version of the Oct. 21, 2025, press release, MDaudit Spotlights the Vital Role of Health…
THOUSAND OAKS, Calif., Oct. 22, 2025 /PRNewswire/ -- Lightfully Behavioral Health has announced the expansion of its clinical services to…
Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, Oct.…
Based on a Black Book Research flash survey of 97 HIM leaders conducted at AHIMA 2025 last week. MINNEAPOLIS, MN…